异动解读 | 分析师下调目标价,Twist Bioscience盘中大跌5.4%

异动解读
Aug 05

周二盘中,生物技术公司Twist Bioscience(TWST)股价出现大幅下跌,跌幅达5.4%,引发市场关注。

造成股价下跌的主要原因可能是多家华尔街分析师下调了该公司的目标股价。根据最新报告,摩根大通将Twist Bioscience的目标价从33美元下调至25美元,而TD Cowen则将目标价从58美元大幅下调至36美元。这些目标价的下调反映了分析师对公司未来表现的预期降低。

分析师目标价的下调通常会对投资者信心产生负面影响,导致股价承压。Twist Bioscience今日的股价走势似乎印证了这一点。投资者可能正在重新评估公司的增长前景和估值水平。目前尚不清楚是否有其他因素影响了股价,投资者应密切关注公司未来的财务报告和业务发展情况。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10